The Company expects second quarter 2025 revenues of $18 million to $20 million and gross margin in the 55% to 57% range.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HBIO:
- HBIO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Harvard Bioscience’s Bertrand Loy to Step Down
- Harvard Bioscience CFO Resignation and Interim Appointment
- Harvard Bioscience CFO Jennifer Cote resigns, Mark Frost named interim CFO
- Harvard Bioscience downgraded to Sector Weight from Overweight at KeyBanc